Anzeige
Mehr »
Freitag, 05.09.2025 - Börsentäglich über 12.000 News
SuperBuzz x Prymatica: Ein Vertriebsdeal, der KI-Hype in B2B-Umsätze verwandeln könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40WGA | ISIN: GB00BQVXM815 | Ticker-Symbol: 5HU0
Frankfurt
05.09.25 | 08:00
6,850 Euro
+12,30 % +0,750
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
HEMOGENYX PHARMACEUTICALS PLC Chart 1 Jahr
5-Tage-Chart
HEMOGENYX PHARMACEUTICALS PLC 5-Tage-Chart
RealtimeGeldBriefZeit
8,2008,55014:58

Aktuelle News zur HEMOGENYX PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08:14Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity153THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018...
► Artikel lesen
MiHemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity211THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018...
► Artikel lesen
MiHemogenyx Pharma Plc - Exercise of Warrants and Issue of Equity3
DiHemogenyx Pharmaceuticals to issue convertible loan notes1
HEMOGENYX PHARMACEUTICALS Aktie jetzt für 0€ handeln
MoHemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes217THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018...
► Artikel lesen
MoHemogenyx Pharmaceuticals raises £620,000 via convertible loan notes2
MoHemogenyx Pharmaceuticals nimmt 620.000 £ über Wandelanleihen auf8
MoHemogenyx Pharma Plc - Issue of convertible loan notes1
29.08.Hemogenyx Pharmaceuticals PLC Announces Result of Audit Tender167LONDON, UK / ACCESS Newswire / August 29, 2025 / Hemogenyx Pharmaceuticals plc (LSE: HEMO), is pleased to announce that following the conclusion of the formal tender process for the role of statutory...
► Artikel lesen
29.08.Hemogenyx Pharma Plc - Result of Audit Tender1
26.08.Hemogenyx stock rises on PS570,000 fundraise for Chimeric trials2
26.08.Hemogenyx Pharmaceuticals PLC: Hemogenyx raises £570,000 and Director's Dealing213THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018...
► Artikel lesen
26.08.Hemogenyx Pharma Plc - Hemogenyx raises £570,000 and Director's Dealing2
15.08.Hemogenyx completes first dose cohort in leukemia CAR-T trial3
15.08.Hemogenyx Pharmaceuticals PLC - Third Patient Treated with HG-CT-1 CAR-T Therapy166Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Third Patient Treated with HG-CT-1 CAR-T Therapy and Completion of First Adult Dose Cohort LONDON, UNITED KINGDOM / ACCESS...
► Artikel lesen
15.08.Hemogenyx Pharma Plc - Third Patient Treated with HG-CT-1 CAR-T Therapy-
31.07.Hemogenyx Pharma Plc - Total Voting Rights-
29.07.Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £250,000 and Director's Dealing371THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018...
► Artikel lesen
29.07.Hemogenyx Pharma Plc - Placing to Raise £250,000 and Director's Dealing-
16.07.Hemogenyx Pharmaceuticals PLC: Hemogenyx Awarded Grant227Hemogenyx Pharmaceuticals Awarded G-Rex® Grant to Support Scalable, Cost-Optimized CAR-T Manufacturing LONDON, UK / ACCESS Newswire / July 16, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased...
► Artikel lesen
Weiter >>
75 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1